– Confessions of the Clinical Minds – A Women In Bio Event Recap –
In light of my commitment to continue sharing posts on networking opportunities and career development for women within the Chicagoland area, I am sharing my latest involvement with Women in Bio; an event made possible by Astellas Pharma and Imperial CRS.
On March 19, 2015, the Chicago Chapter of Women in Bio held its annual event honoring Women’s History Month. This year’s event was held at Astellas Pharma in Northbrook, Illinois, and the discussion focused on late stage clinical trials.
In true form characteristic of WIB events, the evening started with a networking reception and hors d’oeuvres, followed by a panel discussion, and it concluded with a post-discussion coffee and dessert networking opportunity. During the networking reception, guests had the opportunity to meet the speakers and ask any questions, as well as network with other professional women in the life sciences.
The distinguished panel speakers were all women renowned in the industry as leaders. They addressed the advantages and challenges of the development and operations of clinical trials. Among the topics of discussion were: emerging trends related to compliance and public perception, effects of mobile technology and social media platforms in patient recruitment and retention, and the pros and cons of outsourcing clinical trials.
The panelists were asked a variety of questions related to conducting clinical trials in the US and globally. The discussion kicked off with the question, “How have recent Sunshine Act requirements and EFPIA Transparence requirements impacted plans and engagement in Clinical Development?” The panel agreed that the Sunshine Act has allowed for more transparency in study design and implementation, however, it has also created challenges such as the application of various new technologies in order to support the disclosure of data.
In answer to the question “Where do you see the future of clinical trial strategy heading?” the panel argued that, several years ago, the industry was focused on initiating trials in the BRIC countries. However, due to various quality issues with the data that resulted in countries like India, what we are seeing today is that sponsors are forced to be dynamic in how they will be conducting new trials.
The discussion continued with the question “How has personalized medicine impacted clinical studies?” The panel indicated that “Sponsor companies have started to involve patient advocates in protocol design. Moreover, technologies like Fitbit and Apple’s Research Kit, which are currently being used for observational purposes, may eventually be used in the development of clinical trial design.”
In conclusion to the discussion, the speakers shared their advice for other women in the life sciences industry and the various career endeavors they might follow. The collective message was to discover all ranges of the industry and be open minded when researching various career options.
For more information on Women in Bio and upcoming events in the Chicago area, click here.